TGF-β1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease

Clinical Cardiology

Volumn 33, Issue 3, 2010, Pages 149-156

  Xiao, Hua ^a   Lei, Han ^a   Qin, Shu ^a   Ma, Kanghua ^a   Wang, Xi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBROSIS; HEART RIGHT ATRIUM; HUMAN; MALE; MITRAL VALVE REPLACEMENT; PROTEIN EXPRESSION; RHEUMATIC HEART DISEASE; SINUS RHYTHM; ADOLESCENT; BIOSYNTHESIS; CARDIOMYOPATHY; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEART VALVE REPLACEMENT; MITRAL VALVE; PATHOLOGY; RISK FACTOR; STATISTICS;

ADOLESCENT; ADULT; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; COLLAGEN; FEMALE; FIBROSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; MYOCARDIUM; RHEUMATIC HEART DISEASE; RISK FACTORS; RNA, MESSENGER; STATISTICS AS TOPIC; STROKE VOLUME; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 77949768174     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20713     Document Type: Article

References (23)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415(6868):219-226.
2. Nattel S, Shiroshita-Takeshita A, Cardin S, et al. Mechanisms of atrial remodeling and clinical relevance. Curr Opin Cardiol. 2005;20(1):21-25.
3. Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007;4(3 Suppl):24-27.
4. Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci. 2008;65(10): 1489-1508.
5. Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res. 2002;54(2):361-379.
6. Li X, Ma C, Dong J, et al. The fibrosis and atrial fibrillation: is the transforming growth factor-β1 a candidate etiology of atrial fibrillation. Med Hypotheses. 2008;70(2):317-319.
7. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-β in cardiomyopathy, valvular disease and arrhythmia. Immunology. 2006;118(1):10-24.
8. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180-1184.
9. Boldt A, Wetzel U, Lauschke J, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004;90(4):400-405.
10. Mariscalco G, Engstrom KG, Ferrarese S, et al. Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg. 2006;131(6): 1364-1372.
11. Nakai T, Chandy J, Nakai K, et al. Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology. 2007;108(2):90-96.
12. Polyakova V, Miyagawa S, Szalay Z, et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med. 2008;12(1):189-208.
13. Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation. 2004;109(3):363-368.
14. Lijnen P, Petrov V. Transforming growth factor-β1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol. 2002;24(6):333-344.
15. Davidson JM, Zoia O, Liu JM. Modulation of transforming growth factor-β1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor-alpha, and insulin-like growth factor-I. J Cell Physiol. 1993;155(1):149-156.
16. Wu XY, Yang YM, Guo H, et al. The role of connective tissue growth factor, transforming growth factor β1 and SMAD signaling pathway in cornea wound healing. Chin Med J (Engl). 2006;119(1): 57-62.
17. Bujak M, Frangogiannis NG. The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007;74(2):184-195.
18. Huang J, Qin GH, Hu CX, et al. Effects of transforming growth factor-β1 and signal protein SMAD3 on rat cardiomyocyte hypertrophy. Chin Med J (Engl). 2004;117(10):1471-1475.
19. Nakajima H, Nakajima HO, Salcher O, et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-β (1) transgene in the heart. Circ Res. 2000;86(5): 571-579.
20. Rosenkranz S, Flesch M, Amann K, et al. Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β(1). Am J Physiol Heart Circ Physiol. 2002;283(3):H1253-H1262.
21. Verheule S, Sato T, Everett T, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-β1. Circ Res. 2004;94(11):1458-1465.
22. On YK, Jeon ES, Lee SY, et al. Plasma transforming growth factor β1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. J Thorac Cardiovasc Surg. 2009;137(6):1515-1520.
23. Gramley F, Lorenzen J, Koellensperger E, et al. Atrial fibrosis and atrial fibrillation: the role of the TGF-β (1) signaling pathway. Int J Cardiol. 2009.